Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|July 12, 2023
Case Report: A severe case of immunosuppressant-refractory immune checkpoint inhibitor-mediated colitis rescued by tofacitinibMark W D Sweep, Martijn J H Tjan, Mark A J Gorris, et al.
Trends in Cancer|November 10, 2017
Migrating into the Tumor: a Roadmap for T CellsLieke L van der Woude, Mark A J Gorris, Altuna Halilovic, et al.
Frontiers in Immunology|March 6, 2024
Dendritic cell vaccination combined with carboplatin/paclitaxel for metastatic endometrial cancer patients: results of a phase I/II trialBouke J Koeneman, Gerty Schreibelt, Mark A J Gorris, et al.
Acta Obstetricia Et Gynecologica Scandinavica|June 11, 2022
PD-L1 in gestational trophoblastic disease: an antibody evaluationYvonne M Hoeijmakers, Michiel Simons, Johan Bulten, et al.
Journal of Leukocyte Biology|March 21, 2025
Distinct roles of PGE2 signaling via EP2 and EP4 in circulating pDCs: Implications for immune modulation in the tumor microenvironmentJorge Cuenca-Escalona, Mark W D Sweep, Mark A J Gorris, et al.
Frontiers in Immunology|October 14, 2022
The immune microenvironment landscape shows treatment-specific differences in rectal cancer patientsCristina Graham Martínez, Yari Barella, Sonay Kus Öztürk, et al.
Frontiers in Oncology|December 18, 2018
Spontaneous Regression of Ovarian Carcinoma After Septic Peritonitis; A Unique Case ReportThijs Roelofsen, Christina Wefers, Mark A J Gorris, et al.
Human Reproduction (Oxford, England)|December 26, 2024
Artificial intelligence-based tissue segmentation and cell identification in multiplex-stained histological endometriosis sectionsScott E Korman, Guus Vissers, Mark A J Gorris, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 20, 2019
Peptide-mediated delivery of therapeutic mRNA in ovarian cancerDirk van den Brand, Mark A J Gorris, Alexander H van Asbeck, et al.
Cell Reports|January 30, 2020
Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC VaccinationJasper J P van Beek, Georgina Flórez-Grau, Mark A J Gorris, et al.
Pageof 5